搜索

Reimagining Cancer as Chronic. Extending the Journey of Life.

Reimagining Cancer as Chronic. Extending the Journey of Life.

肿瘤慢病化，为生命续航

了解更多

Don't forget the beginning , overcome all difficulties , and be the vanguard of small molecule innovative drugs.

Don't forget the beginning , overcome all difficulties , and be the vanguard of small molecule innovative drugs.

不忘初心、战胜万难，做小分子创新药的排头兵

了解更多

新闻资讯

NEWS INFORMATION

公司资讯

了解更多

2026/02/03 银珠医药口服小分子免疫抑制剂联合奥希替尼II期临床试验申请获国家药监局批准，用于一线治疗EGFR敏感突变阳性肺癌骨转移患者 2026/02/03 银珠医药口服小分子免疫抑制剂治疗类风湿关节炎I期临床研究获批 2025/04/25 银珠医药与阿斯利康达成临床研究合作协议，开创“小分子免疫药物+靶向药物”联合治疗肺癌骨转移新范式！ 2023/12/28 喜讯！银珠医药荣获“广东省专精特新企业”认定！